Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Herbert Jürgens"'
Autor:
Justus Kreyer, Stefan S. Bielack, Hans Gelderblom, Sebastian Bauer, Michael Schäfers, Matthias Weckesser, Thorsten Simon, Lars Stegger, Volker Vieth, Henk van den Berg, Melina Heinemann, Thomas Kühne, Wolf A Hassenpflug, Uta Dirksen, Herbert Jürgens, Andreas Ranft, Regina Mayer-Steinacker, Thorsten Langer, Selim Corbacioglu
Publikováno v:
Pediatric Blood & Cancer, 65(7)
Pediatric blood & cancer, 65(7). Wiley-Liss Inc.
Pediatric blood & cancer, 65(7). Wiley-Liss Inc.
The Cooperative Ewing Sarcoma Study and the Late Effects Surveillance System of the Society for Paediatric Oncology and Haematology recommend a structured follow-up imaging protocol (FUIP) for patients with Ewing sarcoma (EwS) with decreasing frequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8db2d452fdb5b801ee8bab4d40c482d0
https://hdl.handle.net/1887/96270
https://hdl.handle.net/1887/96270
Autor:
R. Maarten Egeler, Paul J. Orchard, Mary Eapen, Giuseppe Bandini, Paul Veys, Jeffrey H. Davis, Susanne Matthes, Gretchen Eames, Olle Ringdén, K. Scott Baker, Herbert Jürgens, Alexandra H. Filipovich, Paul G. Schlegel, Vasanta Nanduri, Anna Pieczonka, Alain Fischer, Wing Leung, Anne Sirvent, Andrea Biondi, Robert A. Krance, Edoardo Lanino, Wensheng He, Gérard Michel, Kim Vettenranta, Arnaud Dalissier
Publikováno v:
British Journal of Haematology. 169:711-718
Patients with Langerhans cell histiocytosis (LCH) refractory to conventional chemotherapy have a poor outcome. There are currently two promising treatment strategies for high-risk patients: the first involves the combination of 2-chlorodeoxyadenosine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed88ba1409845b835ee0056a7dcc1f44
https://doi.org/10.1111/bjh.13347
https://doi.org/10.1111/bjh.13347
Publikováno v:
European Journal of Cancer Supplements. 5:209-215
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cedf0ad1b8d83279f556c5623eace72d
https://doi.org/10.1016/s1359-6349(07)70042-3
https://doi.org/10.1016/s1359-6349(07)70042-3
Autor:
Dirk Reinhardt, Herbert Jürgens, Katja Masjosthusmann, Nanna Kuhn, Annekathrein Florax, Manfred Schiborr, Michael Paulussen, Gabriele Köhler, Jochen Bruch, Stefan S. Bielack
Publikováno v:
Pediatric Blood & Cancer. 45:846-849
Malignancies from the Ewing family of tumors and acute lymphoblastic leukemia (ALL) are not known to be associated with each other. A 5-year-old girl was incidentally found to suffer from acute lymphoblastic leukemia during bone marrow staging for Ew
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6532bb91f772c3f6f089875a05cdec00
https://doi.org/10.1002/pbc.20265
https://doi.org/10.1002/pbc.20265
Publikováno v:
Strahlentherapie und Onkologie. 177:153-159
Intratumoral hypoxia is associated wit poor prognosis in various solid tumors. Severe and long-lasting hypoxia results in necrosis. The presence of necrosis therefore might also be correlated with unfavorable outcome. This has been demonstrated for h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dccb1f4392a0cb7e0222e8e124d3777f
https://doi.org/10.1007/s00066-001-0804-8
https://doi.org/10.1007/s00066-001-0804-8
Autor:
Frans van Valen, Klaus-Michael Debatin, Simone Fulda, Herbert Jürgens, Borna Truckenbrod, Jürgen Sonnemann, Vera Eckervogt, Barbara Dockhorn-Dworniczak, Axel Hillmann, Joachim Boos, Robert Rödl, Torsten Wessel, Winfried Winkelmann, Lutz Schäfer, Christiane Hoffmann
Publikováno v:
International Journal of Cancer. 88:252-259
We investigated the cytotoxic responsiveness of 40 cell lines derived from representatives of the Ewing's sarcoma family of tumours (ESFT), i.e., Ewing's sarcoma (ES), peripheral primitive neuroectodermal tumour (pPNET) and Askin tumour (AT), to tumo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8901e3aec3d65b9448f5586b40dcb21
https://doi.org/10.1002/1097-0215(20001015)88:2<252::aid-ijc17>3.0.co
https://doi.org/10.1002/1097-0215(20001015)88:2<252::aid-ijc17>3.0.co
Autor:
Alan Craft, Jürgen Dunst, Dieter Harms, Paul A. Voûte, Christian Rübe, Axel Hillmann, Ulrich Göbel, Herbert Jürgens, S. Ahrens, Christiane Hoffmann, Winfried Winkelmann
Publikováno v:
Cancer. 85:869-877
BACKGROUND This article reports on 241 patients each with pelvic Ewing sarcoma registered for studies in Germany, Austria, and the Netherlands from January 1, 1981, until January 31, 1994. One hundred sixty-four patients had localized disease and 87
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1179e3d3070de649475362ce30645afa
https://doi.org/10.1002/(sici)1097-0142(19990215)85:4<869::aid-cncr14>3.0.co
https://doi.org/10.1002/(sici)1097-0142(19990215)85:4<869::aid-cncr14>3.0.co
Autor:
Herbert Jürgens, Anke Dirksen, Johannes E. A. Wolff, Gabriele Mölenkamp, Andrea Kosch, Ellen Däumling
Publikováno v:
Klinische Pädiatrie. 210:390-394
Therapy-related late effects are important for therapeutic decisions in pediatric oncology. We quantified the degree of impairment of independence in daily life in children with cancer. The German questionnaire "Fertigkeitenskala Munster/Heidelberg (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6065a5fdad80c03ecd2c1a5fd567e53c
https://doi.org/10.1055/s-2008-1043909
https://doi.org/10.1055/s-2008-1043909
Autor:
A. Wagner, Joachim Boos, Herbert Jürgens, Gudrun Würthwein, Georg Hempel, Petra Schulze-Westhoff, Sebastian Krümpelmann, Barbara Tillmann
Publikováno v:
Klinische Pädiatrie. 210:159-164
Background Etoposide is a cytotoxic agent which is frequently employed in paediatric oncology and which is available for intravenous as well as oral application. Many advantages of the formulation for oral use have been opposed by concerns about its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cbcfad4af6bf6580fefcbff0fab2897
https://doi.org/10.1055/s-2008-1043872
https://doi.org/10.1055/s-2008-1043872
Autor:
Hans-Joachim Spaar, Richard Pötter, Jörn Treuner, Ewa Koscielniak, Herbert Jürgens, Thomas Klingebiel, Ursula Pertl, Ralf van Heek-Romanowski, Clemens F. Hess, Rainer Rossi, Ullrich Willnow, Christian Schött
Publikováno v:
Medical and Pediatric Oncology. 30:269-275
Background The present study was performed to evaluate the possibilities of relapse treatment in patients heavily pretreated for a soft tissue sarcoma. Patients and Methods Prospective, multicenter study in 44 soft tissue sarcoma (STS) patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bce8af3c117eccd19eec1f31d62f385
https://doi.org/10.1002/(sici)1096-911x(199805)30:5<269::aid-mpo2>3.0.co
https://doi.org/10.1002/(sici)1096-911x(199805)30:5<269::aid-mpo2>3.0.co